CompanyDrug

Shouyao Holdings Receives Approval for CT-3505 ALK Inhibitor Study in NSCLC

CompanyDrug

InnoCare Pharma Doses First Patient in ICP-488 Study for Autoimmune Diseases

CompanyDeals

Convalife Pharmaceuticals Licenses Karus Therapeutics’ CVL237 Globally

CompanyDeals

Unicycive Therapeutics Licenses Renazorb to Lee’s Pharma for Asian Markets

CompanyDrug

HutchMed Initiates China Bridging Study for Tazverik in Follicular Lymphoma

CompanyDeals

Hainan Shuangcheng to Transfer Triptorelin Assets to Chongqing Lummy for USD 4.7M

CompanyDrug

Eccogene Receives FDA Approval for ECC4703 Phase I Study in NASH and Dyslipidemia

Company

HutchMed’s H1 2022 Oncology Sales Surge 82% on Strong Product Performance

CompanyDrug

Lion TCR Enrolls First Patient in LioCyx-M004 Study for HBV-Related Liver Cancer

CompanyDrug

Grand Pharma’s TLX591-CDx and TLX250-CDx Advance in China with NMPA Review

CompanyDeals

OriginCell Therapeutics Raises USD 120M in Series B for Tumor Immunotherapy Pipeline

CompanyDeals

Fosun Pharma to Hike Aitrox Stake to 72.63% for USD 61M